Andre baseline- faktorer hos co - inficerede patienter, som kan associeres med en højere risiko for hepatisk dekompensering, inkluderer behandling med didanosin og forhøjet bilirubin serumkoncentration.
Other baseline factors in co-infected patients that may be associated with a higher risk of hepatic decompensation include treatment with didanosine and elevated bilirubin serum concentration.